Citation 9824

BEDIR,E: KHAN,A: WALKER,LA:. (2002). BIOLOGICALLY ACTIVE STEROIDAL GLYCOSIDES FROM TRIBULUS TERRESTRIS.. 57(7)

Citation Details

TitleBIOLOGICALLY ACTIVE STEROIDAL GLYCOSIDES FROM TRIBULUS TERRESTRIS.
AuthorsBEDIR,E: KHAN,A: WALKER,LA:
Year2002
Volume57
Issue7

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Tribulus terrestris (ZYGOPHYLLACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
ISOLATION AND IDENTIFICATION OF
SPIROSTAN-3-BETA-OL,5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE: 25(S):
None
2
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL,5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE: 25(S):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCPYYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDEFUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDEFUROST-5-ENE-3-BETA-22-DIOL-26-O-BETA-D-GLUCOPYRANOSYL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE,25(R):FUROSTA-22-METHOXY-3-BETA-DIOL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
3
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL,5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE: 25(S):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCPYYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDEFUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDEFUROST-5-ENE-3-BETA-22-DIOL-26-O-BETA-D-GLUCOPYRANOSYL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE,25(R):FUROSTA-22-METHOXY-3-BETA-DIOL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
4
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL,5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE: 25(S):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCPYYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDEFUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDEFUROST-5-ENE-3-BETA-22-DIOL-26-O-BETA-D-GLUCOPYRANOSYL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE,25(R):FUROSTA-22-METHOXY-3-BETA-DIOL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
5
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL,5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE: 25(S):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCPYYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDEFUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDEFUROST-5-ENE-3-BETA-22-DIOL-26-O-BETA-D-GLUCOPYRANOSYL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE,25(R):FUROSTA-22-METHOXY-3-BETA-DIOL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
6
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL,5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE: 25(S):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCPYYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDEFUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDEFUROST-5-ENE-3-BETA-22-DIOL-26-O-BETA-D-GLUCOPYRANOSYL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE,25(R):FUROSTA-22-METHOXY-3-BETA-DIOL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
7
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL,5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE: 25(S):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCPYYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDEFUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDEFUROST-5-ENE-3-BETA-22-DIOL-26-O-BETA-D-GLUCOPYRANOSYL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE,25(R):FUROSTA-22-METHOXY-3-BETA-DIOL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
8Not specified
ISOLATION AND IDENTIFICATION OF
SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
None
9
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
10
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
ACTIVE
11
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
ACTIVE
12Not specified
ISOLATION AND IDENTIFICATION OF
SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
None
13
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
14
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
ACTIVE
15
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-OL-12-ONE,5-ALPHA: 3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
ACTIVE
16Not specified
ISOLATION AND IDENTIFICATION OF
FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCPYYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE
None
17
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCPYYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE
INACTIVE
18
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCPYYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE
INACTIVE
19
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCPYYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE
INACTIVE
20Not specified
ISOLATION AND IDENTIFICATION OF
FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE
None
21
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE
INACTIVE
22
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE
INACTIVE
23
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROST-20(22)-EN-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-25(S)-5-BETA: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE
INACTIVE
24Not specified
ISOLATION AND IDENTIFICATION OF
FUROST-5-ENE-3-BETA-22-DIOL-26-O-BETA-D-GLUCOPYRANOSYL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE,25(R):
None
25
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROST-5-ENE-3-BETA-22-DIOL-26-O-BETA-D-GLUCOPYRANOSYL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE,25(R):
INACTIVE
26
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROST-5-ENE-3-BETA-22-DIOL-26-O-BETA-D-GLUCOPYRANOSYL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE,25(R):
INACTIVE
27
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROST-5-ENE-3-BETA-22-DIOL-26-O-BETA-D-GLUCOPYRANOSYL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE,25(R):
INACTIVE
28Not specified
ISOLATION AND IDENTIFICATION OF
FUROSTA-22-METHOXY-3-BETA-DIOL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
None
29
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROSTA-22-METHOXY-3-BETA-DIOL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
30
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROSTA-22-METHOXY-3-BETA-DIOL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
31
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROSTA-22-METHOXY-3-BETA-DIOL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-O-BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
Show SPARQL Queries (1)